Sue Povey — British geneticist and leader in gene nomenclature
Susan (Sue) Povey (1942–2019) was a British geneticist known for her work in human biochemical genetics and for leading the HUGO Gene Nomenclature Committee to standardize gene names internationally.
Susan "Sue" Povey (1942 – 11 January 2019) was a British geneticist whose career combined laboratory research, academic leadership and international standard-setting. Over several decades she helped shape how human genes are named and described, supporting clearer communication among researchers, clinicians and database curators.
Image gallery
2 ImagesCareer and research
Povey spent the bulk of her research career at the Medical Research Council's Human Biochemical Genetics Unit at the Galton Laboratory, a centre with a long history in human genetics. From 1970 until 2000 she worked on problems in biochemical and human genetics, contributing to the molecular and clinical understanding of inherited traits and disorders. Her work was positioned at the interface of laboratory investigation and the practical needs of genetic diagnosis and data sharing.
Academic posts
In 2000 Povey moved to University College London as a professor, where she continued to teach, advise students and participate in departmental activities before retiring in 2007 and becoming Emeritus. During this period she combined academic duties with service to international genetics initiatives, maintaining close links between research, teaching and applied genetic medicine. For institutional information see University College London.
HUGO Gene Nomenclature Committee
From 1996 to 2007 Povey chaired the HUGO Gene Nomenclature Committee (HGNC). In that role she oversaw efforts to give each human gene a unique, stable and widely accepted name and symbol. Standardized nomenclature reduces ambiguity in the literature, supports accurate clinical reporting and enables consistent indexing in genetic and biomedical databases. The committee she led worked with researchers and database teams around the world; more on the organization is available via HUGO.
- Promoted consistent gene symbols and descriptive names for human genes.
- Encouraged coordination between research groups, clinical laboratories and public databases.
- Balanced historical names, clinical usage and the need for unambiguous identifiers.
Honours and legacy. Povey was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2000 in recognition of her contributions to medical genetics. She retired as an active professor in 2007 and continued to be cited for her role in establishing practical and widely adopted nomenclature standards. Sue Povey died on 11 January 2019 at the age of 76. Her work remains influential in how genetic information is named, catalogued and communicated across research and healthcare.
Povey's career illustrates the importance of combining careful laboratory investigation with community-minded standards work. Clear and stable gene nomenclature is now a routine part of genetics and genomics, and it underpins accurate research reporting, data sharing and patient care—areas to which her leadership made a lasting contribution.
Related articles
Author
AlegsaOnline.com Sue Povey — British geneticist and leader in gene nomenclature Leandro Alegsa
URL: https://en.alegsaonline.com/art/94602
Sources
- ucl.ac.uk : "Sue Povey MD Professor Emeritus of Human Genetics"
- tsalliance.org : In Memoriam: Margaret Susan (Sue) Povey, 1942–2019